Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter December 13, 2018

Bioflavonoids protect cells against halogenated boroxine-induced genotoxic damage by upregulation of hTERT expression

  • Maida Hadzic EMAIL logo , Sanin Haveric , Anja Haveric , Naida Lojo-Kadric , Borivoj Galic , Jasmin Ramic and Lejla Pojskic


Plant bioflavonoids are widely present in the human diet and have various protective properties. In this study, we have demonstrated the capacity of delphinidin and luteolin to increase human telomerase reverse transcriptase (hTERT) expression level and act as protective agents against halogenated boroxine-induced genotoxic damage. Halogenated boroxine K2(B3O3F4OH) (HB), is a novel compound with potential for the treatment of both benign and malignant skin changes. In vivo and in vitro studies have confirmed the inhibitory effects of HB on carcinoma cell proliferation and cell cycle progression as well as enzyme inhibition. However, minor genotoxic effects of HB are registered in higher applied concentrations, but those can be suppressed by in vitro addition of delphinidin and luteolin in appropriate concentrations. Fresh peripheral blood samples were cultivated for 72 h followed by independent and concomitant treatments of HB with luteolin or delphinidin. We analyzed the differences in relative hTERT expression between series of treatments compared with controls, which were based on normalized ratios with housekeeping genes. The obtained results have shown that selected bioflavonoids induce upregulation of hTERT that may contribute to the repair of genotoxic damage in vitro.


1. Ren W, Qiao Z, Wang H, Zhu L, Zhang L. Flavonoids: promising anticancer agents. Med Res Rev 2003;23:519–34.10.1002/med.10033Search in Google Scholar PubMed

2. Ezic J, Kugic A, Hadzic M, Haveric A, Bajrovic K, Haveric S. Analysis of delphinidin and luteolin genotoxicity in human lymphocyte culture. J Health Sci 2015;5:41–5.10.17532/jhsci.2015.248Search in Google Scholar

3. Hadzic M, Haveric S, Haveric A, Galic B. Inhibitory effects of delphinidin and luteolin on genotoxicity induced by K2(B3O3F4OH) in human lymphocytes in vitro. Biologia 2015;70:553–8.10.1515/biolog-2015-0066Search in Google Scholar

4. Galic B. Boroxine composition for removal of skin changes. Patent US 8,278,289B2, 2 October 2012.Search in Google Scholar

5. Galic B. Removal of skin changes. Patent EP 1,996,514B1, 31 July 2013.Search in Google Scholar

6. Haveric S, Haveric A, Bajrovic K, Galic B, Maksimovic M. Effects of dipotassium trioxohydroxytetrafluorotriborate (K2[B3O3F4OH]) on genetic material and inhibition of cell division in human cell cultures. Drug Chem Toxicol 2011;34:250–4.10.3109/01480545.2010.507207Search in Google Scholar PubMed

7. Pojskic L, Haveric S, Lojo-Kadric N, Hadzic M, Haveric A, Galic Z, et al. Effects of dipotassium-trioxohydroxytetrafluorotriborate, K2[B3O3F4OH], on cell viability and gene expression of common human cancer drug targets in a melanoma cell line. J Enzyme Inhib Med Chem 2016;31:999–1004.10.3109/14756366.2015.1078329Search in Google Scholar

8. Islamovic S, Galic B, Milos M. A study of the inhibition of catalase by dipotassium trioxohydroxytetrafluorotriborate K2[B3O3F4OH]. J Enzyme Inhib Med Chem 2014;29:744–8.10.3109/14756366.2013.848203Search in Google Scholar PubMed

9. Vullo D, Milos M, Galic B, Scozzafava A, Supuran CT. Dipotassium trioxohydroxytetrafluorotriborate K2[B3O3F4OH], is a potent inhibitor of human carbonic anhydrases. J Enzyme Inhib Med Chem 2015;30:341–4.10.3109/14756366.2014.918610Search in Google Scholar PubMed

10. Haveric S, Hadzic M, Haveric A, Mijanovic M, Hadziselimovic R, Galic B. Genotoxicity evaluation of dipotassium-trioxohydroxytetrafluorotriborate, K2(B3O3F4OH), in human lymphocyte cultures and mice reticulocytes. Braz Arch Biol Technol 2016;59:e16160195.10.1590/1678-4324-2016160195Search in Google Scholar

11. Cortés F, Pastor N, Mateos S, Domínguez I. Roles of DNA topoisomerases in chromosome segregation and mitosis. Mutat Res 2003;543:59–66.10.1016/S1383-5742(02)00070-4Search in Google Scholar PubMed

12. Blasco MA, Hahn WC. Evolving views of telomerase and cancer. Trends Cell Biol 2013;13:289–94.10.1016/S0962-8924(03)00085-0Search in Google Scholar

13. Shin KH, Kang MK, Dicterow E, Kameta A, Baluda MA, Park NH. Introduction of human telomerase reverse transcriptase to normal human fibroblasts enhances DNA repair capacity. Clin Cancer Res 2004;10:2551–60.10.1158/1078-0432.CCR-0669-3Search in Google Scholar PubMed

14. Zhou J, Ding D, Wang M, Cong YS. Telomerase reverse transcriptase in the regulation of gene expression. BMB Reports 2014;47:8–14.10.5483/BMBRep.2014.47.1.284Search in Google Scholar PubMed PubMed Central

15. George VC, Rupasinghe HP. Apple flavonoids suppress carcinogen-induced DNA damage in normal human bronchial epithelial cells. Oxid Med Cell Longev 2017;2017:1767198.10.1155/2017/1767198Search in Google Scholar PubMed PubMed Central

16. Gavande NS, Vere-Carozza PS, Hinshaw HD, Jalal SI, Sears CR, Pawelczak KS, et al. DNA repair targeted therapy: the past or future of cancer treatment? Pharmacol Ther 2016;160:65–83.10.1016/j.pharmthera.2016.02.003Search in Google Scholar PubMed PubMed Central

17. Hsieh MH, Chen YT, Chen YT, Lee XH, Lu J, Chien CL, et al. PARP1 controls KLF4-mediated telomerase expression in stem cells and cancer cells. Nucl Acid Res 2017;45:10492–503.10.1093/nar/gkx683Search in Google Scholar PubMed PubMed Central

18. Peterson SE, Stellwagen AE, Diede SJ, Singer MS, Haimberger ZW, Johnson CO, et al. The function of a stem-loop in telomerase RNA is linked to the DNA repair protein Ku. Nat Genet 2001;27:64–7.10.1038/83778Search in Google Scholar PubMed

19. Holt SE, Aisner DL, Baur J, Tesmer VM, Dy M, Ouellette M, et al. Functional requirement of p23 and Hsp90 in telomerase complexes. Genes Dev 1999;13:817–26.10.1101/gad.13.7.817Search in Google Scholar PubMed PubMed Central

20. Ryss IG, Slutskaya MM. Report on the platinum sector. Dokl Akad Nauk SSSR 1951;26:216.Search in Google Scholar

21. Fenech M. Cytokinesis-block micronucleus assay. Nat Protoc 2007;2:1084–104.10.1038/nprot.2007.77Search in Google Scholar PubMed

22. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29:e45.10.1093/nar/29.9.e45Search in Google Scholar PubMed PubMed Central

23. Masutomi K, Possemato R, Wong JM, Currier JL, Tothova Z, Manola JB, et al. The telomerase reverse transcriptase regulates chromatin state and DNA damage responses. Proc Natl Acad Sci USA 2005;102:8222–7.10.1073/pnas.0503095102Search in Google Scholar PubMed PubMed Central

24. Fleisig HB, Hukezalie KR, Thompson CA, Au-Yeung TT, Ludlow AT, Zhao CR, et al. Telomerase reverse transcriptase expression protects transformed human cells against DNA-damaging agents, and increases tolerance to chromosomal instability. Oncogene 2016;35:218–27.10.1038/onc.2015.75Search in Google Scholar PubMed

25. Pandita RK, Chow TT, Udayakumar D, Bain AL, Cubeddu L, Hunt CR, et al. Single-strand DNA-binding protein SSB1 facilitates TERT recruitment to telomeres and maintains telomere G-overhangs. Cancer Res 2015;75:858–69.10.1158/0008-5472.CAN-14-2289Search in Google Scholar PubMed PubMed Central

26. Sharma GG, Gupta A, Wang H, Scherthan H, Dhar S, Gandhi V, et al. hTERT associates with human telomeres and enhances genomic stability and DNA repair. Oncogene 2003;22:131–46.10.1038/sj.onc.1206063Search in Google Scholar PubMed

27. Luca VS, Miron A, Aprotosoaie AC. The antigenotoxic potential of dietary flavonoids. Phytochem Rev 2016;15:591–625.10.1007/s11101-016-9457-1Search in Google Scholar

28. Kandaswami C, Lee LT, Lee PP, Hwang JJ, Ke FC, Huang YT, et al. The antitumor activities of flavonoids. In Vivo 2005;19:895–909.Search in Google Scholar PubMed

29. George VC, Dellaire G, Rupasinghe HP. Plant flavonoids in cancer chemoprevention: role in genome stability. J Nutr Biochem 2017;45:1–14.10.1016/j.jnutbio.2016.11.007Search in Google Scholar PubMed

30. Collins AR, Harrington V, Drew J, Melvin R. Nutritional modulation of DNA repair in a human intervention study. Carcinogenesis 2003;24:511–5.10.1093/carcin/24.3.511Search in Google Scholar PubMed

31. Ramos AA, Pereira-Wilson C, Collins AR. Protective effects of ursolic acid and luteolin against oxidative DNA damage include enhancement of DNA repair in Caco-2 cells. Mutat Res 2010;692:6–11.10.1016/j.mrfmmm.2010.07.004Search in Google Scholar PubMed

32. Kanakis CD, Tarantilis PA, Polissiou MG, Diamantoglou S, Tajmir-Riahi HA. DNA interaction with naturally occurring antioxidant flavonoids quercetin, kaempferol, and delphinidin. J Biomol Struct Dyn 2005;22:719–24.10.1080/07391102.2005.10507038Search in Google Scholar PubMed

33. Tawani A, Kumar A. Structural insight into the interaction of flavonoids with human telomeric sequence. Sci Rep 2015;5:17574.10.1038/srep17574Search in Google Scholar PubMed PubMed Central

34. Lamy E, Goetz V, Erlacher M, Herz C, Mersch-Sundermann V. hTERT: another brick in the wall of cancer cells. Mutat Res 2013;752:119–28.10.1016/j.mrrev.2012.12.005Search in Google Scholar PubMed

Received: 2018-08-30
Revised: 2018-11-02
Accepted: 2018-11-23
Published Online: 2018-12-13
Published in Print: 2019-05-27

©2019 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 6.12.2023 from
Scroll to top button